Suppr超能文献

血管免疫母细胞性淋巴结病患者的克隆性基因重排模式与免疫表型及临床参数相关。

Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.

作者信息

Feller A C, Griesser H, Schilling C V, Wacker H H, Dallenbach F, Bartels H, Kuse R, Mak T W, Lennert K

机构信息

Institute of Pathology, University of Kiel, Federal Republic of Germany.

出版信息

Am J Pathol. 1988 Dec;133(3):549-56.

Abstract

T cell receptor beta (TcR beta) chain gene rearrangements have been reported in cases of angioimmunoblastic lymphadenopathy (AILD) and provided evidence for the presence of clonal T cell proliferations in this disorder. Twenty-three cases of AILD and two cases of hyperimmune reaction (HR) were investigated. In the two HR cases, essentially the same histologic pattern was present as in AILD but lymph node follicles were hyperplastic. Both HR cases showed germline configuration for the TcR and immunoglobulin heavy chain (IgH) genes. All other patients diagnosed with AILD had clonal rearrangements for TcR gamma and beta chain genes. In addition, seven out of these cases had clonally rearranged their IgH genes. These two different rearrangement patterns (TcR with or without Ig gene rearrangement) correlated to immunohistochemical and clinical data. Cases with TcR but without Ig gene rearrangements (group I) exclusively showed CD4+ proliferating T cells, whereas those cases with TcR and Ig gene rearrangements had significantly elevated numbers of CD8+ proliferating cells (group II). Group II patients significantly more often presented with hemolytic anemia and went into transient remission spontaneously or under steroid treatment. Group I patients, however, had a higher response to chemotherapy and a longer survival time. These data show that, based on different rearrangement patterns, it is possible to divide AILD into two different groups with distinct immunophenotypic properties and differences in clinical parameters. Immunogenotyping in AILD thus will have prognostic and therapeutic implications.

摘要

血管免疫母细胞性淋巴结病(AILD)病例中已报道有T细胞受体β(TcRβ)链基因重排,这为该疾病中克隆性T细胞增殖的存在提供了证据。对23例AILD病例和2例高免疫反应(HR)病例进行了研究。在2例HR病例中,其组织学模式与AILD基本相同,但淋巴结滤泡增生。这2例HR病例的TcR和免疫球蛋白重链(IgH)基因均显示种系构型。所有其他诊断为AILD的患者的TcRγ和β链基因均有克隆性重排。此外,这些病例中有7例其IgH基因发生了克隆性重排。这两种不同的重排模式(TcR有或无Ig基因重排)与免疫组化和临床数据相关。仅有TcR但无Ig基因重排的病例(I组)仅显示CD4 +增殖性T细胞,而那些有TcR和Ig基因重排的病例CD8 +增殖细胞数量显著增加(II组)。II组患者更常出现溶血性贫血,并且自发或在类固醇治疗下进入短暂缓解期。然而,I组患者对化疗的反应更高,生存时间更长。这些数据表明,基于不同的重排模式,有可能将AILD分为具有不同免疫表型特征和临床参数差异的两个不同组。因此,AILD中的免疫基因分型将具有预后和治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/582a/1880823/28bf2483744c/amjpathol00129-0135-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验